ClinConnect ClinConnect Logo
Search / Trial NCT05385523

Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery

Launched by ARMED FORCES COLLEGE OF MEDICINE, CAIRO, EGYPT · May 20, 2022

Trial Information

Current as of July 21, 2025

Unknown status

Keywords

ClinConnect Summary

Rhomboid intercostal block (RIB); a new interfascial plane block involves the triangle of auscultation that's bounded medially by inferior a part of the trapezius, inferiorly by the superior border of latissimus dorsi, and laterally by the medial border of the scapula. The local anaesthetic spreads between the rhomboid major and therefore the intercostal fascia at the extent of T6-T7 and provides analgesia of T3-T8 dermatomes.

Aiming to expand dermatomal coverage, a new modification of Rhomboid Intercostal and Sub-Serratus block (RISS) is performed by advancing the ultrasound probe caudall...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult female patient
  • Type of surgery; Modified Radical Mastectomy (MRM).
  • Physical status ASA II, III.
  • Age ≥ 21 and ≤ 65 Years.
  • Body mass index (BMI): \> 20 kg/m2 and \< 35 kg/m2.
  • Exclusion Criteria:
  • Patient refusal.
  • Patients suffering from coagulation disorders.
  • Patients with histories of allergic reactions to local anesthetics or dexmedetomidine.
  • Patients suffering from neuropsychiatric disorders.
  • Pregnancy.

About Armed Forces College Of Medicine, Cairo, Egypt

The Armed Forces College of Medicine in Cairo, Egypt, is a prestigious institution dedicated to advancing medical education, research, and healthcare within the military and civilian sectors. As a clinical trial sponsor, the college is committed to conducting rigorous and innovative research that addresses critical health issues, enhances medical practice, and contributes to the body of scientific knowledge. Leveraging its resources and expertise, the college collaborates with local and international partners to ensure the highest standards of research integrity, safety, and ethical compliance, ultimately striving to improve health outcomes for diverse populations.

Locations

Patients applied

0 patients applied

Trial Officials

Bassant Abdelhamid, MD

Principal Investigator

AFCM Egypt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials